Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

被引:82
作者
Kasahara, Y
Wada, T
Niida, Y
Yachie, A
Seki, H
Ishida, Y
Sakai, T
Koizumi, F
Koizumi, S
Miyawaki, T
Taniguchi, N
机构
[1] Kanazawa Univ, Sch Med, Dept Pediat, Kanazawa, Ishikawa 920, Japan
[2] Ehime Univ, Fac Med, Dept Pediat, Matsuyama, Ehime 79102, Japan
[3] Toyama Med & Pharmaceut Univ, Dept Pathol 2, Toyama 93001, Japan
[4] Toyama Med & Pharmaceut Univ, Dept Pediat, Toyama 93001, Japan
关键词
apoptosis; sFas; sFas ligand; T cell activation;
D O I
10.1093/intimm/10.2.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fas is an apoptosis-signaling receptor important for homeostasis of the immune system. In this study, Fas-mediated apoptosis and Fas mutations were analyzed in three Japanese children from two families with a lymphoproliferative disorder characterized by lymphadenopathy, hepatosplenomegaly, pancytopenia, hypergammaglobulinemia and an increase in TCR alpha beta(+)CD4(-)CD8(-) T cells, Apoptosis induced by anti-fas mAb was defective in both activated T cells and a cells, and granulocytes from these patients. Truncated Fas receptor lacking the cytoplasmic death domain caused by a point mutation in the splice region of intron 7 were demonstrated in two siblings, A homozygous point mutation in the splice acceptor of intron 3 was found in the Fas gene of the third patient, which resulted in the skipping of exon 4 and complete loss of Fas expression, Corresponding to these mutations, soluble Fas concentrations were decreased and reciprocally soluble Fas ligands were increased in patients' sera, Interestingly, co-stimulation by immobilized anti-fas mAb in T cells from the two siblings was comparable to that seen in normal T cells, These results suggest that Fas-mediated apoptosis plays a pivotal role in immunological homeostasis in vivo, especially regarding clonal deletion of immune cells in humans.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 41 条
[21]   Involvement of reactive oxygen intermediates in spontaneous and CD95(Fas/APO-1)-mediated apoptosis of neutrophils [J].
Kasahara, Y ;
Iwai, K ;
Yachie, A ;
Ohta, K ;
Konno, A ;
Seki, H ;
Miyawaki, T ;
Taniguchi, N .
BLOOD, 1997, 89 (05) :1748-1753
[22]   IDENTIFICATION OF SOLUBLE APO-1 IN SUPERNATANTS OF HUMAN B-CELL AND T-CELL LINES AND INCREASED SERUM LEVELS IN B-CELL AND T-CELL LEUKEMIAS [J].
KNIPPING, E ;
DEBATIN, KM ;
STRICKER, K ;
HEILIG, B ;
EDER, A ;
KRAMMER, PH .
BLOOD, 1995, 85 (06) :1562-1569
[23]   Clinical, immunological, and pathological consequences of Fas-deficient conditions [J].
LeDeist, F ;
Emile, JF ;
RieuxLaucat, F ;
Benkerrou, M ;
Roberts, I ;
Brousse, N ;
Fischer, A .
LANCET, 1996, 348 (9029) :719-723
[24]  
LEITHAUSER F, 1993, LAB INVEST, V69, P415
[25]   FAS AND FASL IN THE HOMEOSTATIC REGULATION OF IMMUNE-RESPONSES [J].
LYNCH, DH ;
RAMSDELL, F ;
ALDERSON, MR .
IMMUNOLOGY TODAY, 1995, 16 (12) :569-574
[26]   APO-1 MEDIATED APOPTOSIS OR PROLIFERATION IN HUMAN CHRONIC B-LYMPHOCYTIC LEUKEMIA - CORRELATION WITH BCL-2 ONCOGENE EXPRESSION [J].
MAPARA, MY ;
BARGOU, R ;
ZUGCK, C ;
DOHNER, H ;
USTAOGLU, F ;
JONKER, RR ;
KRAMMER, PH ;
DORKEN, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (03) :702-708
[27]  
MIYAWAKI T, 1992, J IMMUNOL, V149, P3753
[28]   THE FAS DEATH FACTOR [J].
NAGATA, S ;
GOLSTEIN, P .
SCIENCE, 1995, 267 (5203) :1449-1456
[29]   FAS AND FAS LIGAND - LPR AND GLD MUTATIONS [J].
NAGATA, S ;
SUDA, T .
IMMUNOLOGY TODAY, 1995, 16 (01) :39-43
[30]  
OEHM A, 1992, J BIOL CHEM, V267, P10709